SUN-171 Glargine Use in a Neonatal Diabetic
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2019-sun-171
Abstract: Abstract BACKGROUND Neonatal Diabetes (ND) is rare with incidence estimated at 1 / 100,000-500,000 live births. Duration of ND and insulin requirements vary with average therapy lasting 3 months. Genetic mutations are reported in 90%… read more here.
Keywords: continuous insulin; glargine; insulin; insulin infusion ... See more keywords